Explore the latest in ophthalmic devices, including recent FDA approvals of devices for treatment of eye disease.
This randomized clinical trial investigates if the implantation of a capsular tension ring reduces intraocular lens decentration and tilt in all highly myopic eyes.
This case report describes a diagnosis of dystrophic calcification of a silicone intraocular lens implant in a patient who presented with foggy vision and glare.
This case report discusses a diagnosis of foreign body granuloma resulting from a punctal plug in a patient aged 66 years with chronic dry eye and a history of blepharoplasty.
This cross-sectional study evaluates a relatively simple, noninvasive measurement method for exophthalmos using a smartphone.
This case report discusses the finding of pseudoexfoliative material on the intraocular lens implant of a patient with a history of pseudoexfoliation syndrome and secondary glaucoma.
This systematic review and network meta-analysis compares outcomes of presbyopia-correcting intraocular lenses frequently recommended in clinical practice.
This cohort study analyzes the risk of injuries and visual quality for driving among patients who underwent bilateral surgery for cataracts and received implants with blue light–filtering or non–blue light–filtering intraocular lenses.
This Viewpoint discusses the efforts by the US Food and Drug Administration (FDA) to balance flexibility in the regulatory requirements to facilitate ophthalmic device innovation while assuring that these products are safe and effective.
This case report describes a 13-year-old girl with a history of penetrating trauma who developed multiple spokelike deposits over the anterior and posterior surface of an intraocular lens.
This case report describes a rare case of cutaneous malignant melanoma metastatic to the intraocular lens.
This case report describes unilateral pseudoexfoliation deposits on the anterior surface of the intraocular lens of an elderly patient.
This case report describes a full-thickness cornea graft treatment for recurrent conjunctival dehiscence after Argus II implant to avoid explant.
This case report describes an unusual sequal to the implantation of an intraocular lens and describes the method used to correct it.
This Viewpoint describes US Food and Drug Administration programs designed with the aim of enhancing and expediting the regulatory process to bring ophthalmic devices to patients more rapidly and efficiently.
This case report describes a 41-year-old man with visual obscuration in his eye after a fluocinolone acetonide intravitreal implant 5 years ago.
This Special Communication from The Ophthalmic Digital Health Workshop discusses the challenges of balancing providing patients with the most current innovations in ophthalmic digital health and maintaining appropriate safety and efficacy screening.
This multicenter case series follows-up 47 patients who received the Argus II retinal prosthesis for severe to profound outer retinal degeneration to assess visual function and adverse events in the first year after implantation.
This Special Communication analyzes a 2018 Cochrane systematic review of studies that evaluated the efficacy and safety of blue light–filtering intraocular lenses for providing protection to macular health and function.
Customize your ÌÇÐÄvlog experience by selecting one or more topics from the list below.